Covert drug dependence should be the null hypothesis for explaining drug-withdrawal-induced clinical deterioration: The necessity for placebo versus drug withdrawal trials on normal control subjects

Medical Hypotheses

Volumn 74, Issue 5, 2010, Pages 761-763

  Charlton, Bruce G ^a  

^a UNIVERSITY OF BUCKINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; NEUROLEPTIC AGENT;

ALCOHOL WITHDRAWAL; ALCOHOLISM; CHRONIC DISEASE; CHRONIC DRUG ADMINISTRATION; CLINICAL RESEARCH; DELIRIUM TREMENS; DRUG DEPENDENCE; DRUG RESEARCH; DRUG WITHDRAWAL; EDITORIAL; EVIDENCE BASED MEDICINE; HUMAN; PLACEBO EFFECT; WITHDRAWAL SYNDROME;

CONTROL GROUPS; HUMANS; PLACEBO EFFECT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SUBSTANCE WITHDRAWAL SYNDROME; SUBSTANCE-RELATED DISORDERS;

EID: 77950944941     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2010.02.015     Document Type: Editorial

References (1)

1. Healy D. Treatment induced stress syndromes. Med Hypotheses 2010, 74(5):764-768.